Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 22:41:01 UTC
Update Date2022-11-23 22:29:21 UTC
HMDB IDHMDB0259780
Secondary Accession NumbersNone
Metabolite Identification
Common NameVeralipride
DescriptionVeralipride, also known as agreal, belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. Based on a literature review a significant number of articles have been published on Veralipride. This compound has been identified in human blood as reported by (PMID: 31557052 ). Veralipride is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Veralipride is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
AgrealKegg
2,3-Dimethoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-5-sulphamoylbenzamideGenerator
MenofelMeSH
N-(1-Allyl-2-pyrrolidinyl)methyl-2,3-dimethoxy-5-sulfamoylbenzamideMeSH
VeraligralMeSH
VeraliprideMeSH
Veralipride monohydrochlorideMeSH
2,3-Dimethoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-5-sulfamoylbenzene-1-carboximidateGenerator
2,3-Dimethoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-5-sulphamoylbenzene-1-carboximidateGenerator
2,3-Dimethoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-5-sulphamoylbenzene-1-carboximidic acidGenerator
Chemical FormulaC17H25N3O5S
Average Molecular Weight383.46
Monoisotopic Molecular Weight383.151492091
IUPAC Name2,3-dimethoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-5-sulfamoylbenzene-1-carboximidic acid
Traditional Nameagreal
CAS Registry NumberNot Available
SMILES
COC1=CC(=CC(C(O)=NCC2CCCN2CC=C)=C1OC)S(N)(=O)=O
InChI Identifier
InChI=1S/C17H25N3O5S/c1-4-7-20-8-5-6-12(20)11-19-17(21)14-9-13(26(18,22)23)10-15(24-2)16(14)25-3/h4,9-10,12H,1,5-8,11H2,2-3H3,(H,19,21)(H2,18,22,23)
InChI KeyRYJXBGGBZJGVQF-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBenzenesulfonamides
Direct ParentBenzenesulfonamides
Alternative Parents
Substituents
  • Benzenesulfonamide
  • O-dimethoxybenzene
  • Dimethoxybenzene
  • Benzamide
  • Benzenesulfonyl group
  • Benzoic acid or derivatives
  • Phenoxy compound
  • Anisole
  • Benzoyl
  • Methoxybenzene
  • Phenol ether
  • Alkyl aryl ether
  • N-alkylpyrrolidine
  • Organosulfonic acid amide
  • Pyrrolidine
  • Organic sulfonic acid or derivatives
  • Organosulfonic acid or derivatives
  • Aminosulfonyl compound
  • Sulfonyl
  • Tertiary aliphatic amine
  • Tertiary amine
  • Amino acid or derivatives
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Ether
  • Carboxylic acid derivative
  • Azacycle
  • Organoheterocyclic compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organosulfur compound
  • Organic nitrogen compound
  • Amine
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1.26ALOGPS
logP-0.53ChemAxon
logS-3.3ALOGPS
pKa (Strongest Acidic)5.93ChemAxon
pKa (Strongest Basic)8.61ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area114.45 ŲChemAxon
Rotatable Bond Count8ChemAxon
Refractivity100.03 m³·mol⁻¹ChemAxon
Polarizability39.71 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+189.27132859911
AllCCS[M+H-H2O]+186.64632859911
AllCCS[M+Na]+192.38232859911
AllCCS[M+NH4]+191.6932859911
AllCCS[M-H]-185.11132859911
AllCCS[M+Na-2H]-185.65432859911
AllCCS[M+HCOO]-186.38332859911
DeepCCS[M+H]+186.1330932474
DeepCCS[M-H]-183.77230932474
DeepCCS[M-2H]-216.84830932474
DeepCCS[M+Na]+192.22430932474

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.3.77 minutes32390414
Predicted by Siyang on May 30, 20229.9117 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20223.88 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid821.0 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid195.7 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid124.5 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid169.0 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid58.4 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid256.5 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid333.5 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)551.1 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid672.0 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid98.1 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid782.6 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid192.0 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid232.1 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate605.1 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA427.7 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water103.5 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
VERALIPRIDECOC1=CC(=CC(C(O)=NCC2CCCN2CC=C)=C1OC)S(N)(=O)=O4414.2Standard polar33892256
VERALIPRIDECOC1=CC(=CC(C(O)=NCC2CCCN2CC=C)=C1OC)S(N)(=O)=O3216.8Standard non polar33892256
VERALIPRIDECOC1=CC(=CC(C(O)=NCC2CCCN2CC=C)=C1OC)S(N)(=O)=O3187.7Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
VERALIPRIDE,2TMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C)C1=CC(S(=O)(=O)N[Si](C)(C)C)=CC(OC)=C1OC3104.3Semi standard non polar33892256
VERALIPRIDE,2TMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C)C1=CC(S(=O)(=O)N[Si](C)(C)C)=CC(OC)=C1OC3274.4Standard non polar33892256
VERALIPRIDE,2TMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C)C1=CC(S(=O)(=O)N[Si](C)(C)C)=CC(OC)=C1OC4395.3Standard polar33892256
VERALIPRIDE,2TMS,isomer #2C=CCN1CCCC1CN=C(O)C1=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC3169.9Semi standard non polar33892256
VERALIPRIDE,2TMS,isomer #2C=CCN1CCCC1CN=C(O)C1=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC3295.5Standard non polar33892256
VERALIPRIDE,2TMS,isomer #2C=CCN1CCCC1CN=C(O)C1=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC4479.8Standard polar33892256
VERALIPRIDE,3TMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C)C1=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC3072.5Semi standard non polar33892256
VERALIPRIDE,3TMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C)C1=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC3401.5Standard non polar33892256
VERALIPRIDE,3TMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C)C1=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC4218.5Standard polar33892256
VERALIPRIDE,2TBDMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C(C)(C)C)C1=CC(S(=O)(=O)N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC3547.4Semi standard non polar33892256
VERALIPRIDE,2TBDMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C(C)(C)C)C1=CC(S(=O)(=O)N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC3804.9Standard non polar33892256
VERALIPRIDE,2TBDMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C(C)(C)C)C1=CC(S(=O)(=O)N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC4365.1Standard polar33892256
VERALIPRIDE,2TBDMS,isomer #2C=CCN1CCCC1CN=C(O)C1=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC3639.0Semi standard non polar33892256
VERALIPRIDE,2TBDMS,isomer #2C=CCN1CCCC1CN=C(O)C1=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC3808.4Standard non polar33892256
VERALIPRIDE,2TBDMS,isomer #2C=CCN1CCCC1CN=C(O)C1=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC4484.0Standard polar33892256
VERALIPRIDE,3TBDMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C(C)(C)C)C1=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC3764.8Semi standard non polar33892256
VERALIPRIDE,3TBDMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C(C)(C)C)C1=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC4131.5Standard non polar33892256
VERALIPRIDE,3TBDMS,isomer #1C=CCN1CCCC1CN=C(O[Si](C)(C)C(C)(C)C)C1=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC4239.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Veralipride GC-MS (Non-derivatized) - 70eV, Positivesplash10-0n2c-8539000000-d9518ec171c0acd3317e2021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Veralipride GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Veralipride GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Veralipride GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Veralipride GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Veralipride GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Veralipride 10V, Positive-QTOFsplash10-001i-1509000000-75d0dc530728918c6acd2016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Veralipride 20V, Positive-QTOFsplash10-0076-7933000000-b13a596530a13dc63a132016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Veralipride 40V, Positive-QTOFsplash10-0006-9100000000-1d40c6d66483d827b6502016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Veralipride 10V, Negative-QTOFsplash10-001i-0019000000-4dc43e9ebbf71dcbf1122016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Veralipride 20V, Negative-QTOFsplash10-004l-4925000000-f51b5f0c6daa85233b452016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Veralipride 40V, Negative-QTOFsplash10-004i-9042000000-83e9f20b91a8cc3f19452016-08-03Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB13523
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID43638
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkVeralipride
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]